Milestone Pharmaceuticals Stock Wilted: Midweek Decline
Investors weighed the promise of Milestone Pharmaceuticals against the realities of a high-stakes biotech market. Thi...
Yearly performance of total market index funds provides a broad view of winners and laggards. Use these insights to adjust your exposure today.
28,320 articlesInvestors weighed the promise of Milestone Pharmaceuticals against the realities of a high-stakes biotech market. Thi...
A February market shock erased roughly $285B in software valuations, forcing a rethink of what truly drives software ...
Bitcoin again hovers near the 70K mark as XRP mirrors BTC moves. A test of AI forecasting asks what XRP bottoms could...
Ethereum breached a critical support level, signaling renewed downside risk. This report breaks down the factors, key...
Curve rolls out Llamalend v2 on Optimism, expanding collateral and borrowing options. The upgrade comes with a 250,00...
A $50 million real estate deal nearly unraveled after both sides leaned on ChatGPT for pricing guidance. The episode ...
A veteran fund manager challenges Wall Street's reliance on earnings when valuing AI plays, arguing that the E in P/E...
Netflix reports strong cash generation as Disney funds parks and legacy assets with heavy capex, spotlighting two dis...
A record $182 billion in AI-focused bond issuance this year is fueling an infrastructure wave, but investors warn tha...
SK Hynix shares rebound 8% amid bargain-hunting after HSBC reaffirmed SKHY as a top chip pick. The move comes as inve...
Lemonade's shares swung wildly in a single session, rising on an earnings beat and then tumbling as expectations cool...
Jamie Dimon warns of parallels to the pre-financial crisis era as asset prices and volumes stay elevated. The JPMorga...